{"id":"W4281877709","doi":"10.1007/s13555-022-00746-6","title":"Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat Psoriasis","year":2022,"lang":"en","type":"review","venue":"Dermatology and Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Janssen Biotech; Allergan; LEO Pharma; Bausch Health; Regeneron Pharmaceuticals; Sun Pharma; Bristol-Myers Squibb; Eli Lilly and Company; Ortho Dermatologics; Galderma; Incyte; Valeant Pharmaceuticals International; Celgene; Amgen; Pfizer","keywords":"Medicine; Psoriasis; Dermatology; Ixekizumab; Secukinumab; Scalp; Psoriatic arthritis","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005848207,0.0007151987,0.00161721,0.002823138,0.0002677216,0.001162731,0.0007855967,0.0008955841,0.00513685],"category_scores_gemma":[0.001311398,0.0002777845,0.0008242119,0.002710602,0.0002836264,0.001056785,0.000595912,0.001151593,0.001155173],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005232241,"about_ca_system_score_gemma":0.001333103,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001012326,"about_ca_topic_score_gemma":0.001873589,"domain_scores_codex":[0.9997589,0.00005071239,0.0000600425,0.00003945938,0.00007401938,0.00001681987],"domain_scores_gemma":[0.9994507,0.0003187882,0.0001061907,0.000009249857,0.00008733464,0.00002775382],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001321825,0.00005633706,0.0001469771,0.154656,0.0003101325,0.0003679132,0.0001379944,0.0003126526,0.0009742656,0.00260987,0.05427277,0.7860228],"study_design_scores_gemma":[0.0000384729,0.0001164296,0.0009910517,0.04510114,0.0006613472,0.002523224,0.0001032836,0.00008893693,0.0002660951,0.00129518,0.9487879,0.00002693986],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006233081,0.9991069,0.00004091677,0.0001505812,0.0001606076,0.000006735219,0.00002483297,0.000002977152,0.0004440785],"genre_scores_gemma":[0.0003561339,0.9990335,0.00008638115,0.0001824049,0.0001246125,0.0000069545,0.00002859321,8.150217e-7,0.0001807784],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00513685,"threshold_uncertainty_score":0.0171845,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02688408479749728,"score_gpt":0.2961091200770096,"score_spread":0.2692250352795124,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}